People News

Share this article:

Progenics Pharmaceuticals promoted Mark Baker to the newly created position of president. Baker will continue to report to Paul Maddon, the company's founder. Baker will be responsible for overseeing the company's commercial development, strategic planning, business development, communications, finance and accounting, operations and legal affairs, according to a company statement. He was also promoted to Progenics' board of directors.

Swiss specialty pharma Addex Pharmaceuticals' head of business development Laurent Massuyeau has resigned, the company announced, without further explanation. He was also a member of the executive management team.


Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters